Synlogic (NASDAQ:SYBX) Shares Cross Below 50-Day Moving Average – Should You Sell?

Synlogic, Inc. (NASDAQ:SYBX)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.35 and traded as low as $1.27. Synlogic shares last traded at $1.31, with a volume of 1,037 shares.

Synlogic Price Performance

The stock has a market cap of $15.31 million, a PE ratio of -0.31 and a beta of 0.72. The company’s fifty day moving average is $1.35 and its 200-day moving average is $1.41.

Synlogic (NASDAQ:SYBX) last released its quarterly earnings data on Thursday, March 6th. The biotechnology company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.04. Analysts expect that Synlogic, Inc. will post -2.71 EPS for the current year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.